Cathie Wood: AI to Cut Drug Discovery, Development Costs
Cathie Wood, the founder, CEO and chief investment officer of Ark Investment Management, discusses how artificial intelligence could positively impact the health care sector. “AI is going to collapse the cost of drug discovery and development,” Wood tells Bloomberg Television.